Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
04 March, 2015 01:47 IST
Aurobindo gains on USFDA approval for Oxacillin
Source: IRIS | 21 Jan, 2013, 11.47AM
Comments  |  Post Comment

Aurobindo Pharma, a mid-size pharmaceutical company, gained on Monday after it has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Oxacillin for Injection USP, packaged in 1g and 2g vials and Oxacillin for Injection USP 10g/Vial pharmacy bulk package.

Oxacillin for Injection USP is a sterile semisynthetic penicillin (SSP) indicated in the treatment of infections caused by penicillinase producing staphylococci which have demonstrated susceptibility to the drug.

Shares of the company are trading at Rs 195.70, up Rs 3.1, or 1.61% at the Bombay Stock Exchange (BSE) on Monday at 11:42 a.m.

The scrip has touched an intra-day high of Rs 196.70 and low of Rs 193.10. The total volume of shares traded at the BSE is 105,697.

In the earlier session, the shares gained 2.15%, or Rs 4.05, at Rs 192.60. Currently, the stock is trading down 4.49% from its 52-week high of Rs 204.90 and above 104.81% over the 52-week low of Rs 95.55.



Share Price Movement
Period Price
in Rs
Gain/(Loss)
in Rs in %
1 Week 184.55 8.05 4.36
1 Month 195.10 (2.50) (1.28)
3 Months 156.80 35.80 22.83
6 Months 108.40 84.20 77.68
1 Year 100.10 92.50 92.41
Note: Based on previous day closing price.


Aurobindo Pharma Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Nitin Fire Protection receives UL approval for 'clean agent suppression system' - 03-Mar-2015 16:43
DCB Bank advises Kashmir Finance for fund raising - 03-Mar-2015 15:54
CG board approves scheme for vertical demerger of consumer products business - 03-Mar-2015 15:18
ErosNow partners with GTPL - 03-Mar-2015 14:28
Nectar Lifesciences bags European cGMP nod for Cephalosporin APIs - 03-Mar-2015 14:11
Bharti's African tower sales to reduce debt, but could be offset by spectrum payments: Moody's - 03-Mar-2015 14:04
Titan commences stainless steel production in Coimbatore - 03-Mar-2015 14:00
Bharti Airtel announces strategic collaboration with China Mobile - 03-Mar-2015 13:46
SBI and Coromandel Intl' join hands for sustainable rural development - 03-Mar-2015 13:26
Moody's downgrades CBI and IOB to 'Ba1' - 03-Mar-2015 13:26
Moody's downgrades CBI and IOB to 'Ba1' - 03-Mar-2015 13:26
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer